Published guidance, NICE advice and quality standards | Guidance

Showing 281 to 290 of 334

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer	TA285	22 May 2013	22 May 2013
Early and metastatic HER2-positive breast cancer: subcutaneous trastuzumab	ESNM13	13 March 2013	13 March 2013
Irreversible electroporation for treating primary lung cancer and metastases in the lung	HTG302	23 February 2013	23 February 2013
Irreversible electroporation for treating renal cancer	HTG303	23 February 2013	23 February 2013
Neutropenic sepsis: prevention and management in people with cancer	CG151	19 September 2012	19 September 2012
Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer	TA263	22 August 2012	22 August 2012
Lapatinib or trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer that overexpresses HER2	TA257	27 June 2012	27 June 2012
Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancer	TA258	27 June 2012	27 June 2012
Focal therapy using cryoablation for localised prostate cancer	HTG284	26 April 2012	26 April 2012
Cetuximab, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after first-line chemotherapy	TA242	25 January 2012	25 January 2012